Market Trends of Global Gene Synthesis Industry
This section covers the major market trends shaping the Gene Synthesis Market according to our research experts:
PCR-mediated Assembly is Expected to Occupy a Major Share in the Studied Market Over Forecast Period
PCR-mediated recombination is a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA. In the gene synthesis process, chemical synthesis is typically used to create oligonucleotides of up to 120-150 nucleotides (nt) in length. Therefore, generally, gene assembly techniques are utilized to connect small oligonucleotides, to synthesize the gene of the required length. Over the past three decades, several methods have been developed to assemble relatively short synthetic oligonucleotides into longer gene sequences. And the polymerase chain reaction (PCR) - mediated assembly represents one of the most prominent approaches to the mediating assembly of the desired DNA sequence.
About the broad applications of polymerase chain reaction (PCR) systems, such as in molecular diagnostics, forensics, and epidemiology studies, the demand and acceptance of polymerase chain reaction technologies are high, which, in turn, acts as a favorable factor for the development and adoption of PCR-mediated assembly methodologies, by academia and research institutes alike. The polymerase chain reaction (PCR) technique played a very important role in concluding the Human Genome Project in 2003. Also, the key market players are working towards improving the polymerase chain reaction technique to expand its nucleic acid synthesis capacity. For example, in April 2020, Biolytic Lab announced the launch of its advanced oligo synthesizer, for high-throughput nucleic acid synthesis, called Dr. Oligo 768XLc DNA RNA Synthesizer. Therefore, owing to the above-mentioned factors, the segment is expected to witness significant growth in the future.
North America Region is Expected to Hold a Significant Share in the Gene Synthesis Market
North America is comprised of the United States, Canada, and Mexico. Currently, North America dominates the market for gene synthesis and is expected to continue its stronghold in the coming future.
In the North American region, the United States holds the largest market share as compared to Canada and Mexico. The increasing prevalence of genetic and chronic disorders, such as cancer, the aging population, increasing demand for targeted and personalized medicine, and favorable government initiatives are the primary factors responsible for the large market. Another factor responsible for the dominance of the United States is the presence of key market players in the region and the high volume of ongoing scientific research activities. In the fiscal year of 2021, the National Cancer Institute of the United States was allocated a budget of USD 6.56 billion solely for cancer research.
Hence, owing to the increased funding for certain diseases and the well-established healthcare, the United States is believed to dominate the market studied.
